-
KOSPI 2577.27 -2.21 -0.09%
-
KOSDAQ 722.52 -7.07 -0.97%
-
KOSPI200 341.49 +0.02 +0.01%
-
USD/KRW 1396 -2.00 0.14%
CEPI
Search results
-
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
